相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase
Rosario Pivonello et al.
LANCET DIABETES & ENDOCRINOLOGY (2020)
CUDC-907 displays potent antitumor activity against human pancreatic adenocarcinoma in vitro and in vivo through inhibition of HDAC6 to downregulate c-Myc expression
Xu-hong Fu et al.
ACTA PHARMACOLOGICA SINICA (2019)
Panobinostat andMultipleMyeloma in 2018
Andrew J. Yee et al.
ONCOLOGIST (2018)
CUDC-907 in relapsed/refractory diffuse large B-cell lymphoma, including patients with MYC-alterations: results from an expanded phase I trial
Yasuhiro Oki et al.
HAEMATOLOGICA (2017)
Histone Deacetylase Inhibitor SAHA Is a Promising Treatment of Cushing Disease
Jie Lu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Increased β-catenin and c-myc expression predict aggressive growth of non-functioning pituitary adenomas: An assessment using a tissue microarray-based approach
Chunhui Liu et al.
MOLECULAR MEDICINE REPORTS (2017)
Targeting Class I Histone Deacetylases in a Complex Environment
Christopher J. Millard et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2017)
Dual inhibition of histone deacetylases and phosphoinositide 3-kinase enhances therapeutic activity against B cell lymphoma
Patrizia Mondello et al.
ONCOTARGET (2017)
CUDC-907 in relapsed/refractory diffuse large B-cell lymphoma, including patients with MYC-alterations: results from an expanded phase I trial
Yasuhiro Oki et al.
HAEMATOLOGICA (2017)
AlphaLISA immunoassays: the no-wash alternative to ELISAs for research and drug discovery
Lucille Beaudet et al.
NATURE METHODS (2017)
Histone deacetylase 11 suppresses p53 expression in pituitary tumor cells
Weimin Wang et al.
CELL BIOLOGY INTERNATIONAL (2017)
Limited value of cabergoline in Cushing's disease: a prospective study of a 6-week treatment in 20 patients
Pia Burman et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)
Safety, tolerability, and preliminary activity of CUDC-907, a first-in-class, oral, dual inhibitor of HDAC and PI3K, in patients with relapsed or refractory lymphoma or multiple myeloma: an open-label, dose-escalation, phase 1 trial
Anas Younes et al.
LANCET ONCOLOGY (2016)
Targeting the ERK pathway for the treatment of Cushing's disease
Dongyun Zhang et al.
ONCOTARGET (2016)
The Treatment of Cushing's Disease
Rosario Pivonello et al.
ENDOCRINE REVIEWS (2015)
The Gene of the Ubiquitin-Specific Protease 8 Is Frequently Mutated in Adenomas Causing Cushing's Disease
Luis G. Perez-Rivas et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline
Lynnette K. Nieman et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Histone Deacetylases Positively Regulate Transcription through the Elongation Machinery
Celeste B. Greer et al.
CELL REPORTS (2015)
Targeting the histone orthography of cancer: drugs for writers, erasers and readers
Laia Simo-Riudalbas et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Incidence of Cushing's syndrome and Cushing's disease in commercially-insured patients <65 years old in the United States
Michael S. Broder et al.
PITUITARY (2015)
Erasers of Histone Acetylation: The Histone Deacetylase Enzymes
Edward Seto et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2014)
HDAC inhibitors induce transcriptional repression of high copy number genes in breast cancer through elongation blockade
Y. J. Kim et al.
ONCOGENE (2013)
Remission rate after transsphenoidal surgery in patients with pathologically confirmed Cushing's disease, the role of cortisol, ACTH assessment and immediate reoperation: a large single center experience
Nadia Hameed et al.
PITUITARY (2013)
Evidence for orphan nuclear receptor TR4 in the etiology of Cushing disease
Li Du et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Cancer Network Disruption by a Single Molecule Inhibitor Targeting Both Histone Deacetylase Activity and Phosphatidylinositol 3-Kinase Signaling
Changgeng Qian et al.
CLINICAL CANCER RESEARCH (2012)
HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity
Mitsumasa Kurita et al.
NATURE NEUROSCIENCE (2012)
Cabergoline monotherapy in the long-term treatment of Cushing's disease
Ariane Godbout et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2010)
Involvement of Nuclear Factor-kappa B and Nurr-1 in Cytokine-Induced Transcription of Proopiomelanocortin Gene in AtT20 Corticotroph Cells
Shinobu Takayasu et al.
NEUROIMMUNOMODULATION (2010)
Genome-wide Mapping of HATs and HDACs Reveals Distinct Functions in Active and Inactive Genes
Zhibin Wang et al.
CELL (2009)
The Medical Treatment of Cushing's Disease: Effectiveness of Chronic Treatment with the Dopamine Agonist Cabergoline in Patients Unsuccessfully Treated by Surgery
Rosario Pivonello et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Liver X Receptor-alpha Regulates Proopiomelanocortin (POMC) Gene Transcription in the Pituitary
Shunichi Matsumoto et al.
MOLECULAR ENDOCRINOLOGY (2009)
Suberoylanilide hydroxamic acid (SAHA) induces growth arrest and apoptosis in pituitary adenoma cells
S. R. Sangeetha et al.
ENDOCRINE (2009)
Late recurrences of Cushing's disease after initial successful transsphenoidal surgery
Chirag G. Patil et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
FDA approval summary: Vorinostat for treatment of advanced primary cutaneous T-cell lymphoma
Bhupinder S. Mann et al.
ONCOLOGIST (2007)
Role of Brg1 and HDAC2 in GR trans-repression of the pituitary POMC gene and misexpression in Cushing disease
Steve Bilodeau et al.
GENES & DEVELOPMENT (2006)
Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance
AB Atkinson et al.
CLINICAL ENDOCRINOLOGY (2005)
Pituitary surgery and postoperative management in Cushing's disease
AL Utz et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2005)
A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells
E Yeh et al.
NATURE CELL BIOLOGY (2004)
分享论文
